Putnam Investments’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.62M Sell
61,102
-24,648
-29% -$767K ﹤0.01% 699
2023
Q3
$2.23M Buy
85,750
+61,470
+253% +$1.28M ﹤0.01% 690
2023
Q2
$581K Sell
24,280
-766
-3% -$13.2K ﹤0.01% 907
2023
Q1
$342K Buy
25,046
+1,508
+6% +$24K ﹤0.01% 1056
2022
Q4
$327K Buy
+23,538
New +$332K ﹤0.01% 1057

Other funds holding BHVN

Putnam Investments's BHVN Position: Q4 2023 in Review

Putnam Investments reduced its Biohaven (BHVN) stake by 29% in Q4 2023, selling an estimated $767K and leaving 61,102 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #699.

Putnam Investments first reported a position in BHVN in Q4 2022 and has held it in 5 quarters since. 218 funds tracked by Wall St. Rank hold BHVN as of Q4 2023.

  • Putnam Investments held 61,102 shares of Biohaven worth $2.62M as of Q4 2023.
  • Putnam Investments sold 24,648 Biohaven shares in Q4 2023, an estimated $767K.
  • Biohaven made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #699 holding.
  • Putnam Investments first reported a position in Biohaven in Q4 2022 and has held it in 5 quarters since.
  • 218 funds tracked by Wall St. Rank held Biohaven as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.